Meeting
2013 Genitourinary Cancers Symposium
Validation of the pretreatment neutrophil-lymphocyte ratio as prognostic factor regarding cancer-specific, metastasis-free, and overall survival in a European cohort of patients with renal cell carcinoma.
Authors
Georg C. Hutterer
Department of Urology, Medical University of Graz, Graz, Austria
Georg C. Hutterer , Martin Pichler , Caroline Stoeckigt , Thomas F. Chromecki , Tatjana Stojakovic , Silvia Golbeck , Armin Gerger , Karl Pummer , Richard Zigeuner
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
General Poster Session C: Renal Cancer
Track
Renal Cell Cancer
Sub Track
Renal Cell Cancer
Citation
J Clin Oncol 31, 2013 (suppl 6; abstr 410)
DOI
10.1200/jco.2013.31.6_suppl.410
Abstract #
410
Poster Bd #
E15
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Genitourinary Cancers Symposium
The predictive value of hematological markers in renal cell carcinoma.
First Author: Omar Al Ta'ani
Poster
2019 Gastrointestinal Cancers Symposium
Sidedness in metastatic colorectal carcinoma: Which are the factors which influence the prognosis?
First Author: Maria Kogay
Poster
2014 Genitourinary Cancers Symposium
Utilizing percentage of sarcomatoid differentiation as a prognostic factor in renal cell carcinoma.
First Author: Timothy Kim
Poster
2024 ASCO Genitourinary Cancers Symposium
Outcomes and prognostic factors of first-line combination of immune checkpoint inhibitors (ICIs) and tyrosine kinase inhibitors (TKIs) in TFE3-rearranged renal cell carcinoma.
First Author: Junjie Zhao